A study of precision radiomics in the evaluation of lymph node metastasis in early gastric cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036010

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Gold Standard:Postoperative pathological examination

Index test:precision radiomics

Eligibility

Sex/Gender

Male

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with gastric adenocarcinoma by gastroscopy and pathological biopsy in our hospital (including gastroesophageal junction adenocarcinoma type II and type III); 2) patient aged 18 to 85 years old; 3) No chemotherapy, radiotherapy, traditional Chinese medicine or other treatments were performed before operation; 4) The patients received abdominal enhanced CT before operation in our hospital; 5) The pathologic examination showed early gastric cancer, which means the primary lesion infiltrated into the mucosal layer or submucosa.

Exclusion criteria

Exclusion criteria: Stump gastric cancer.

Design outcomes

Primary

Measure	Time frame
Accuracy of preoperative precision radiomics for predicting lymph node metastasis of early gastric cancer;	—

Countries

China

Contacts

Public ContactLiu Fenglin

Zhongshan Hospital, Fudan University

liu.fenglin@zs-hospital.sh.cn+86 021-64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026